Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition
Board of Regents' Distinctions honor the recipients for their outstanding contributions and excellence.
Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.
The team used a computational math theory to identify gene-gene interactions that may be good targets for treating basal-like cancers that are resistant to traditional hormone therapies.
